Federal Register / Vol. 77, No. 67 / Friday, April 6, 2012 / Notices 20823 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, Office 

of Public Health Preparedness and 

Response (BSC, OPHPR) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Times and Dates: 10:30 a.m.–6 p.m., May 

1, 2012; 9 a.m.–3:45 p.m., May 2, 2012. 

Place: CDC, 1600 Clifton Road, NE., Roybal 

Campus, Atlanta, Georgia 30329. May 1, 

2012: Building 19, Room 254/255. May 2, 

2012: Building 21, Room 1204A/1204B. 

Status: Open to the public limited only by 

the space available. The meeting room will 

accommodate up to 75 people. Public 

participants should pre-register for the 

meeting as described in Additional 

Information for Public Participants. 

Purpose: This Board is charged with 

providing advice and guidance to the 

Secretary, Department of Health and Human 

Services (HHS), the Assistant Secretary for 

Health (ASH), the Director, Centers for 

Disease Control and Prevention (CDC), and 

the Director, Office of Public Health 

Preparedness and Response (OPHPR), 

concerning strategies and goals for the 

programs and research within OPHPR, 

monitoring the overall strategic direction and 

focus of the OPHPR Divisions and Offices, 

and administration and oversight of peer 

review of OPHPR scientific programs. For 

additional information about the Board, 

please visit: http://www.cdc.gov/phpr/ 

science/counselors.htm. 

Matters To Be Discussed: Agenda items for 

this meeting include: (1) Briefings and BSC 

deliberation on the following topics: CDC 

Laboratory Preparedness; OPHPR Research 

Portfolio Budget; CDC’s Preparedness Index; 

Novel Approaches to Anti-Viral Delivery; 

CDC’s Anthrax Management Team; 

Estimating the Cost of Preparedness; (2) 

Programmatic responses to BSC-approved 

recommendations resulting from external 

peer review of: The Career Epidemiology 

Field Officer (CEFO) Program and the 

Preparedness and Emergency Response 

Research Centers (PERRCs) program; (3) BSC 

liaison representative updates to the Board 

highlighting organizational activities relevant 

to the OPHPR mission; (4) a discussion of a 

proposed ad hoc working group to review the 

Division of Strategic National Stockpile 

(DSNS). 

Agenda items are subject to change as 

priorities dictate. 

Additional Information for Public 

Participants: Members of the public that wish 

to attend this meeting should pre-register by 

submitting the following information by 

email, facsimile, or phone (see Contact 

Person for More Information) no later than 

12:00 noon (EDT) on Monday, April 20, 2012: 

• Full Name, 

• Organizational Affiliation, 

• Complete Mailing Address, 

• Citizenship, and 

• Phone Number or Email Address 

Contact Person for More Information: Carol 

Marsh, OPHPR BSC Coordinator, Centers for 

Disease Control and Prevention, 1600 Clifton 

Road, NE., Mailstop D–44, Atlanta, Georgia 

30333, Telephone: (404) 639–4773; 

Facsimile: (404) 639–7977; Email: 

OPHPR.BSC.Questions@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both the Centers for Disease Control and 

Prevention, and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 30, 2012. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2012–8290 Filed 4–5–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Prospective Grant of Exclusive 

License: Family Healthware 

AGENCY: Technology Transfer Office, 

Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services. 

ACTION: Notice. 

SUMMARY: This is a notice in accordance 

with 35 U.S.C. 209(e) and 37 CFR 

404.7(a)(1)(i) that the Centers for Disease 

Control and Prevention (CDC), 

Technology Transfer Office, Department 

of Health and Human Services (DHHS), 

is contemplating the grant of a 

worldwide, exclusive license to practice 

the inventions embodied in the patent 

application referred to below to Sanitas 

Inc., having a place of business in La 

Jolla, California. The patent rights in 

these inventions have been assigned to 

the government of the United States of 

America. The patent application(s) to be 

licensed are: 

US Patent Application 11/815,445 entitled 

‘‘Personal Assessment Including Familial 

Risk Analysis for Personalized Disease 

Prevention Plan,’’ filed 5/20/2008, claiming 

priority to Provisional Patent Application No. 

60/650,076, filed 2/3/2005. CDC Technology 

ID No. I–004–04. 

Status: Patent Application Pending. 

Priority Date: 2/3/2005. 

Issue Date: N/A. 

The prospective exclusive license will 

be royalty-bearing and will comply with 

the terms and conditions of 35 U.S.C. 

209 and 37 CFR 404.7. 

Technology: This technology provides 

a computer-based familial risk 

assessment tool. It involves a three-step 

process which uses the disease history 

of a person’s first and second-degree 

relatives to assess the risk of common 

diseases of adulthood in order to 

influence early disease detection and 

prevention strategies. 

ADDRESSES: Requests for a copy of this 

patent application, inquiries, comments, 

and other materials relating to the 

contemplated license should be directed 

to Donald Prather, J.D., Ph.D., 

Technology Licensing and Marketing 

Specialist, Technology Transfer Office, 

Centers for Disease Control and 

Prevention (CDC), 4770 Buford 

Highway, Mailstop K–79, Atlanta, GA 

30341, Telephone: (770) 488–8612; 

Facsimile: (770) 488–8615. Applications 

for a license filed in response to this 

notice will be treated as objections to 

the grant of the contemplated license. 

Only written comments and/or 

applications for a license which are 

received by CDC within thirty days of 

this notice will be considered. 

Comments and objections submitted in 

response to this notice will not be made 

available for public inspection, and, to 

the extent permitted by law, will not be 

released under the Freedom of 

Information Act, 5 U.S.C. 552. 

Dated: March 27, 2012. 

Tanja Popovic, 

Deputy Associate Director for Science Centers 

for Disease Control and Prevention. 

[FR Doc. 2012–8291 Filed 4–5–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0332] 

Jyotin Parikh: Debarment Order 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is issuing an 

order under the Federal Food, Drug, and 

Cosmetic Act (the FD&C Act) debarring 

Jyotin Parikh for 5 years from providing 

services in any capacity to a person that 

has an approved or pending drug 

product application. FDA bases this 

order on a finding that Mr. Parikh was 

convicted of one count of conspiracy to 

commit an offense against the United 

States for conduct relating to the 

mstockstill on DSK4VPTVN1PROD with NOTICES